This site uses cookies. By continuing, your consent is assumed. Learn more

130.4m shares

Second-generation non sedating antihistamine pipeline

opinion

The global antihistamines market will grow at a CAGR of 8. Antihistamines exemplify a class of drugs that block the histamine type-1 H1 receptors. H1-receptors are extensively scattered and predominantly found on smooth muscle of the gastrointestinal tract, bronchi, uterus, and large blood vessels. The key applications of antihistamines are allergic rhinitis, conjunctivitis, urticaria, atopic dermatitis, anaphylaxis, and others.

What are antihistamines used for?

In year according to European Academy of Allergy Second-generation non sedating antihistamine pipeline Clinical Immunology EAACIaround million or more Europeans suffer from chronic allergic conditions and further anticipated that by half of the total population of Europe will suffer with chronic allergic diseases.

Thus, rising global prevalence of allergies expected to increase the demand for antihistamines in the near future. Second-generation antihistamines expected to retain its market dominance during the forecast period.

Second-generation antihistamines such as acrivastine, cetirizine, desloratadine, fexofenadine, levocetirizine, and loratadine are preferred as first-line of treatment in diseases such as allergic rhinitis, urticaria, and atopic dermatitis.

Aka: Non-Sedating Antihistamine, Second Generation...

However, the main reason for prescribing second-generation antihistamines is there are very few second-generation antihistamines that cross blood-brain barrier and have sedating effect.

Cetirizine causes drowsiness that may lead to accidents with people driving car or handling heavy machinery. Thus, levocetirizine is now preferred over cetirizine due to its non-sedating effect. Second-generation antihistamines possess a longer duration of action and Second-generation non sedating antihistamine pipeline half-life compared to first generation drugs, which makes it easy to decrease the number of daily intakes. Asia Pacific will exhibit double-digit growth during the forecast period due to increasing patient awareness related to allergic reactions.

Asia Pacific observed as the fastest growing region in antihistamines market due to rising awareness in patients and medical practitioners related to allergic conditions, and developing digital healthcare infrastructure.

The market experts believe that physicians in Asia-Pacific have access to all available second-generation H1- antihistamines due to which they are able to follow international guideline recommendations for first-line treatment of allergic rhinitis and urticaria effectively.

Antihistamines in pipeline Second-generation non sedating antihistamine pipeline on the verge of exploring several other applications. Antihistamines in phase III of clinical trials are exploring applications such as chronic spontaneous urticaria, angioedema, functional dyspepsia, hemodynamic instability, vasoplegic syndrome, elbow injury, and others.

Thus, post approvals for these applications antihistamine market will grow exponentially during the forecast period from to Thus, strong pipeline expected to boost the overall growth of antihistamines market throughout the forecast period. The antihistamines market analyzed considering current market trends for base year and based on future trends CAGRs calculated for the forecast period from to This report on antihistamines market offers in-depth information related to market dynamics and global trends.

The report provides comprehensive summary of the global antihistamines market by segmenting the market based on type of antihistamines and geography. The objective of publishing this in-depth research report is to assist the industry stakeholders "Second-generation non sedating antihistamine pipeline" carrying-out decisions and strategy implementation in the antihistamines market.

Furthermore, the key players are analyzed graphically based on their product offering, market strategies and business strength.

Ebastine does not produce sedation...

The report also provides attractive investment proposition based on the extensive geographical research carried out based on PESTEL analysis. USP and Key Offerings 1. Phase I — Second-generation non sedating antihistamine pipeline Research 1.

Phase II — Primary Research 1. Global Antihistamines Market Portraiture 2. Market Dynamics and Outlook 3.

Antihistamines are classified into two...

Attractive Investment Proposition, by Geography, Second-generation non sedating antihistamine pipeline. Global Antihistamines Market, by Key Players, First Generation Antihistamines 4. Others Carbinoxamine, Dimenhydrinate, and others 4. Second Generation Antihistamines 4. Phase III Forecast till 4. Phase II Tabular Representation. Others Angioedema, Pruritus, and others.

Desloratadine is a frequently used...

Rest of Europe 6. Rest of Asia Pacific 6. Rest of Latin America 6. Financial Information Subject to Data Availability 7. Boehringer Ingelheim GmbH 7.

Teva Pharmaceutical Industries Ltd. Facebook Twitter Google Linkedin. Jul Report Code: Market Synopsis Second-generation antihistamines expected to retain its market dominance during the forecast period Second-generation antihistamines such as acrivastine, cetirizine, desloratadine, fexofenadine, levocetirizine, and loratadine are preferred as first-line of treatment in diseases such as allergic rhinitis, urticaria, and atopic dermatitis.

Asia Pacific will exhibit double-digit growth during the forecast period due to increasing patient awareness related to allergic reactions Asia Pacific observed as the fastest growing region in antihistamines market due to rising awareness in Second-generation non sedating antihistamine pipeline and medical practitioners related to allergic conditions, and developing digital healthcare infrastructure.

Antihistamines in pipeline are on the verge of exploring several other applications Antihistamines in phase III of clinical trials are exploring applications such as chronic spontaneous urticaria, angioedema, functional dyspepsia, hemodynamic instability, vasoplegic syndrome, elbow injury, and others.

Report Scope by Segments This report on antihistamines market offers in-depth information related to market dynamics and global trends. Key questions answered in this report Which are the most preferred drugs prescribed as the first line of treatment in allergic conditions? What are the recent market developments in the antihistamine industry and valuable growth opportunities for the players?

Which are the most promising pipeline drugs in phase III clinical trials? Which geographical markets are suitable for new product launch? What is the market size of North America, and where other regional markets stand in the global competition? Which are the major countries in Asia Pacific antihistamines market considered promising during the Second-generation non sedating antihistamine pipeline expansion? Request For Second-generation non sedating antihistamine pipeline Sample Request.

Others Angioedema, Pruritus, and others Chapter 6. Rest of MEA Chapter 7. Inquiry Before Buying Sample Request. Antihistamines are a class of agents that block histamine release from histamine- 1 receptors and are mostly used to treat allergies or cold and.

Although the second generation antihistamines are known Second-generation non sedating antihistamine pipeline all have similar efficacy, the extent of their sedative effects is not well established. To further.

What are Antihistamines?

Basic symptoms of both allergic and non-allergic rhinitis include:. acting, non- sedating antihistamine (e.g. cetirizine, loratadine, fexofenadine) on an as needed basis. Second-generation antihistamines in nasal form are as good as. Fix all leaky faucets and pipes, and eliminate collections of Second-generation non sedating antihistamine pipeline.

YOU ARE HERE: